Odds, Lines and Spreads

Get MLB odds for Wed March 25, 2026, point spreads, money lines, and over/unders for popular sportsbooks and view expert analysis of each upcoming game ...

ETF inflows are surging: How to understand the price action

Exchange-traded fund (ETF) inflows have already topped $100 billion in 2026.Yahoo Finance Markets and Data Editor Jared Blikre, who also hosts Yahoo Finance's Stocks in Translation podcast, breaks it ...
Yahoo Finance

New England Journal of Medicine Publishes Phase 3 ASCENT-04/KEYNOTE-D19 Results Supporting Trodelvy® Plus Keytruda® as a Potential New Standard of Care in First-line PD-L1 ...

– Combination Reduced the Risk of Death or Disease Progression by 35% Versus Standard of Care in Frontline PD-L1+ Metastatic TNBC Setting – FOSTER CITY, Calif., January 21, 2026--(BUSINESS ...
Pharmabiz

China NMPA grants breakthrough therapy designation to Kelun-Biotech’s sacituzumab tirumotecan in combo with immunotherapy pembrolizumab for first-line treatment of PD-L1 ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (Kelun-Biotech), a holding subsidiary of Kelun Pharmaceutical, which focuses on the R&D, manufacturing, commercialization and global collaboration of ...
Health.com

Does a Faint Line on a COVID Test Mean You're Positive?

Julia is the associate news editor for Health, where she edits and publishes news articles on trending health and wellness topics. Her work has been featured in The Heights, an independent student ...
Morningstar

Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2 ...

Positive Phase 3 Results Support ZIIHERA® as HER2-Targeted Therapy-of-Choice and Combination with TEVIMBRA® and Chemotherapy as New Standard of Care in First-Line HER2-Positive Locally Advanced or ...
Morningstar

Synthekine Presents Positive Initial Results from Phase 1a/1b Clinical Trial of STK-012 Plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous Non-Small ...

Synthekine Presents Positive Initial Results from Phase 1a/1b Clinical Trial of STK-012 Plus Pembrolizumab and Chemotherapy in First-Line, PD-L1 Negative Nonsquamous Non-Small Cell Lung Cancer 53% ...
Business Wire

DATROWAY® (datopotamab deruxtecan-dlnk) demonstrated unprecedented median overall survival improvement of five months vs. chemo as 1st-line treatment for patients with ...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive results from the TROPION-Breast02 Phase III trial showed DATROWAY ® (datopotamab deruxtecan-dlnk) demonstrated a statistically significant and clinically ...
Hosted on MSN

Houston Texans get a positive start from offensive line in preseason opener against Minnesota

MINNEAPOLIS - When starting left tackle Cam Robinson went down with a leg injury on the first day of training camp practices at the Greenbrier last week, there was major concern about how the Texans ...
live.euronext

Edf: 2025 half-year results - Operational performance in line with expectations - Positive cash flow in a context of falling market prices and rising investments Net financial ...

In a context of falling market prices, EBITDA amounts to €15.5 bn vs. €18.7 bn for H1 2024, despite the higher nuclear power output in France. The regulated activities are growing. Despite the ...
Healthline

How to Manage Guilt and Negative Self-Talk When Relaxing

If you experience guilt and anxiety when you’re relaxing, you’re not alone. Productivity guilt is real, but it’s important to remember that rest isn’t a waste of time. Modern society often rewards ...